Literature DB >> 20487416

Influenza: a recurrent challenge to transplantation.

M G Ison, H H Hirsch.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20487416     DOI: 10.1111/j.1399-3062.2010.00501.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


× No keyword cloud information.
  5 in total

Review 1.  Clinical use of approved influenza antivirals: therapy and prophylaxis.

Authors:  Michael G Ison
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

Review 2.  Influenza prevention and treatment in transplant recipients and immunocompromised hosts.

Authors:  Michael G Ison
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380

3.  Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets.

Authors:  Erhard van der Vries; Koert J Stittelaar; Geert van Amerongen; Edwin J B Veldhuis Kroeze; Leon de Waal; Pieter L A Fraaij; Roland J Meesters; Theo M Luider; Bart van der Nagel; Birgit Koch; Arnold G Vulto; Martin Schutten; Albert D M E Osterhaus
Journal:  PLoS Pathog       Date:  2013-05-23       Impact factor: 6.823

Review 4.  A Review of Clinical Influenza A and B Infections With Reduced Susceptibility to Both Oseltamivir and Zanamivir.

Authors:  Yacine Abed; Guy Boivin
Journal:  Open Forum Infect Dis       Date:  2017-05-18       Impact factor: 3.835

5.  Tocilizumab therapy in 5 solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2.

Authors:  Jose A Morillas; Francisco Marco Canosa; Pavithra Srinivas; Tannaz Asadi; Cassandra Calabrese; Prabalini Rajendram; Marie Budev; Emilio D Poggio; K V Narayanan Menon; Brian Gastman; Christine Koval
Journal:  Am J Transplant       Date:  2020-07-22       Impact factor: 9.369

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.